A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling
Statistics in Medicine · 2024
DOI: 10.1002/sim.10077 ↗At a glance
Journal article in Statistics in Medicine, 2024. Written by Wei Wei and 6 co-authors. Institution: Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA. Major MEDLINE topics: Bayes Theorem, Computer Simulation, Randomized Controlled Trials as Topic, Models, Statistical. Cited 5 times so far (Crossref); 23 references. The full text is freely available in PubMed Central. Funded by: NIDCR NIH HHS, NCATS NIH HHS, NIH HHS.
Abstract (original language)
Enrolling patients to the standard of care (SOC) arm in randomized clinical trials, especially for rare diseases, can be very challenging due to the lack of resources, restricted patient population availability, and ethical considerations. As the therapeutic effect for the SOC is often well documented in historical trials, we propose a Bayesian platform trial design with hybrid control based on the multisource exchangeability modelling (MEM) framework to harness historical control data. The MEM approach provides a computationally efficient method to formally evaluate the exchangeability of study outcomes between different data sources and allows us to make better informed data borrowing decisions based on the exchangeability between historical and concurrent data. We conduct extensive simulation studies to evaluate the proposed hybrid design. We demonstrate the proposed design leads to significant sample size reduction for the internal control arm and borrows more information compared to competing Bayesian approaches when historical and internal data are compatible.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.
- Statistical & Quantitative Sciences, Takeda Pharmaceuticals, Cambridge, Massachusetts, USA.
ORCID profiles: Wei Wei, Ondrej Blaha, Denise Esserman, Michael Kane, Rachael Liu, Jianchang Lin
Funding
- NIDCR NIH HHS
- NCATS NIH HHS
- NIH HHS
- NCI NIH HHS
- National Center for Advancing Translational Sciences
- National Institutes of Health
Cite
APA
Wei, W., Blaha, O., Esserman, D., Zelterman, D., Kane, M., Liu, R., & Lin, J. (2024). A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling. Statistics in Medicine. https://doi.org/10.1002/sim.10077
Vancouver
Wei W, Blaha O, Esserman D, Zelterman D, Kane M, Liu R, et al. A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling. Statistics in Medicine. 2024. doi:10.1002/sim.10077
BibTeX
@article{Wei2024,
author = {Wei, Wei and Blaha, Ondrej and Esserman, Denise and Zelterman, Daniel and Kane, Michael and Liu, Rachael and Lin, Jianchang},
title = {A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling},
journal = {Statistics in Medicine},
year = {2024},
doi = {10.1002/sim.10077}
}
EUVIMED